 Julie Haines
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2019 | 527 | 2.640 |
Why?
| | Erythrocytes | 12 | 2019 | 591 | 2.070 |
Why?
| | Cysteine | 8 | 2019 | 171 | 1.670 |
Why?
| | Blood Preservation | 9 | 2019 | 263 | 1.530 |
Why?
| | Nitrogen Oxides | 6 | 2014 | 47 | 1.530 |
Why?
| | Metabolome | 11 | 2019 | 285 | 1.510 |
Why?
| | Oxidation-Reduction | 13 | 2019 | 926 | 0.850 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 15 | 0.800 |
Why?
| | Phosphines | 4 | 2014 | 15 | 0.780 |
Why?
| | Peroxiredoxins | 3 | 2018 | 23 | 0.780 |
Why?
| | Sulfenic Acids | 3 | 2016 | 7 | 0.730 |
Why?
| | Hydrogen Peroxide | 3 | 2018 | 287 | 0.710 |
Why?
| | Proteins | 5 | 2016 | 915 | 0.700 |
Why?
| | Mass Spectrometry | 7 | 2019 | 634 | 0.670 |
Why?
| | Erythrocyte Transfusion | 4 | 2019 | 186 | 0.630 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 11 | 0.620 |
Why?
| | Glycolysis | 7 | 2019 | 227 | 0.620 |
Why?
| | Hydroxylamine | 1 | 2017 | 8 | 0.590 |
Why?
| | Vitreous Body | 1 | 2018 | 101 | 0.580 |
Why?
| | Retinal Detachment | 1 | 2018 | 53 | 0.580 |
Why?
| | Proteome | 2 | 2018 | 339 | 0.550 |
Why?
| | Diabetic Retinopathy | 1 | 2018 | 149 | 0.540 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2019 | 187 | 0.520 |
Why?
| | Proteomics | 4 | 2018 | 844 | 0.510 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2019 | 534 | 0.510 |
Why?
| | Neoplastic Stem Cells | 2 | 2019 | 333 | 0.500 |
Why?
| | Chondrocytes | 2 | 2018 | 199 | 0.490 |
Why?
| | Blood Proteins | 1 | 2017 | 233 | 0.480 |
Why?
| | Succinic Acid | 4 | 2018 | 44 | 0.470 |
Why?
| | Extracellular Matrix | 1 | 2017 | 436 | 0.460 |
Why?
| | Oxidative Phosphorylation | 3 | 2019 | 156 | 0.450 |
Why?
| | Plasma | 3 | 2019 | 210 | 0.450 |
Why?
| | Triazenes | 1 | 2012 | 3 | 0.420 |
Why?
| | Lipids | 2 | 2019 | 586 | 0.420 |
Why?
| | Oxidative Stress | 5 | 2019 | 1085 | 0.420 |
Why?
| | Sulfhydryl Compounds | 2 | 2014 | 177 | 0.400 |
Why?
| | Sulfones | 1 | 2012 | 97 | 0.400 |
Why?
| | Cardiotonic Agents | 1 | 2012 | 119 | 0.400 |
Why?
| | Amino Acids | 3 | 2019 | 452 | 0.390 |
Why?
| | Macrophages | 3 | 2018 | 1267 | 0.390 |
Why?
| | Stomach Ulcer | 1 | 2011 | 9 | 0.380 |
Why?
| | Mitochondria | 3 | 2017 | 750 | 0.370 |
Why?
| | Shock, Hemorrhagic | 3 | 2018 | 193 | 0.370 |
Why?
| | Indomethacin | 1 | 2011 | 75 | 0.370 |
Why?
| | Energy Metabolism | 5 | 2019 | 729 | 0.370 |
Why?
| | Hydroxamic Acids | 1 | 2011 | 80 | 0.360 |
Why?
| | Prodrugs | 1 | 2011 | 42 | 0.360 |
Why?
| | Lipid Metabolism | 3 | 2019 | 449 | 0.350 |
Why?
| | Purines | 3 | 2018 | 159 | 0.350 |
Why?
| | Heart | 2 | 2019 | 610 | 0.350 |
Why?
| | Animals | 25 | 2019 | 31870 | 0.340 |
Why?
| | Electron Transport Complex II | 1 | 2019 | 23 | 0.330 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 430 | 0.330 |
Why?
| | Lung | 3 | 2019 | 3595 | 0.320 |
Why?
| | Nitric Oxide | 2 | 2012 | 827 | 0.320 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 18 | 0.320 |
Why?
| | Organogenesis | 1 | 2019 | 54 | 0.310 |
Why?
| | Gluconates | 1 | 2018 | 4 | 0.310 |
Why?
| | Antacids | 1 | 2018 | 15 | 0.310 |
Why?
| | Rejuvenation | 1 | 2018 | 14 | 0.310 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 399 | 0.310 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 28 | 0.300 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 299 | 0.300 |
Why?
| | Guanosine | 1 | 2018 | 39 | 0.300 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 24 | 0.300 |
Why?
| | Glycogen | 1 | 2017 | 51 | 0.290 |
Why?
| | Fatty Acids | 2 | 2019 | 385 | 0.290 |
Why?
| | Interleukin-1beta | 2 | 2018 | 370 | 0.290 |
Why?
| | Cryopreservation | 2 | 2018 | 92 | 0.290 |
Why?
| | Liver | 3 | 2018 | 1681 | 0.290 |
Why?
| | Reactive Oxygen Species | 6 | 2019 | 536 | 0.280 |
Why?
| | Iron | 1 | 2018 | 234 | 0.280 |
Why?
| | Isotope Labeling | 2 | 2017 | 69 | 0.280 |
Why?
| | Airway Obstruction | 1 | 2019 | 168 | 0.280 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 84 | 0.280 |
Why?
| | High-Throughput Screening Assays | 2 | 2019 | 123 | 0.280 |
Why?
| | Blood Pressure | 1 | 2012 | 1539 | 0.270 |
Why?
| | Humans | 37 | 2019 | 115054 | 0.270 |
Why?
| | Wounds and Injuries | 3 | 2018 | 723 | 0.270 |
Why?
| | Calpain | 1 | 2016 | 53 | 0.260 |
Why?
| | Troponin T | 1 | 2016 | 49 | 0.260 |
Why?
| | Temperature | 1 | 2018 | 578 | 0.250 |
Why?
| | src-Family Kinases | 1 | 2016 | 88 | 0.250 |
Why?
| | Cholestasis | 1 | 2018 | 224 | 0.250 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 107 | 0.240 |
Why?
| | Fetus | 1 | 2019 | 702 | 0.240 |
Why?
| | Cycloparaffins | 1 | 2014 | 2 | 0.240 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2014 | 11 | 0.230 |
Why?
| | Dendritic Cells | 1 | 2017 | 436 | 0.230 |
Why?
| | NF-kappa B | 1 | 2018 | 637 | 0.230 |
Why?
| | Peptide Fragments | 2 | 2016 | 668 | 0.230 |
Why?
| | Acute Lung Injury | 1 | 2017 | 300 | 0.230 |
Why?
| | Cells | 1 | 2014 | 22 | 0.230 |
Why?
| | Dithiothreitol | 1 | 2013 | 17 | 0.230 |
Why?
| | Osteoarthritis | 1 | 2016 | 172 | 0.220 |
Why?
| | Biomarkers | 5 | 2019 | 3419 | 0.220 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2014 | 162 | 0.220 |
Why?
| | Nucleic Acids | 1 | 2014 | 59 | 0.220 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 300 | 0.210 |
Why?
| | Glucose | 2 | 2018 | 900 | 0.200 |
Why?
| | Cartilage, Articular | 1 | 2016 | 289 | 0.200 |
Why?
| | Disease Models, Animal | 7 | 2019 | 3545 | 0.200 |
Why?
| | Mice | 11 | 2019 | 14929 | 0.200 |
Why?
| | Biomedical Research | 1 | 2017 | 585 | 0.190 |
Why?
| | DNA Damage | 1 | 2014 | 357 | 0.190 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 4719 | 0.190 |
Why?
| | Oxidants | 2 | 2019 | 112 | 0.180 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 503 | 0.180 |
Why?
| | S-Nitrosoglutathione | 1 | 2010 | 6 | 0.180 |
Why?
| | S-Nitrosothiols | 1 | 2010 | 4 | 0.180 |
Why?
| | Hemeproteins | 1 | 2010 | 6 | 0.180 |
Why?
| | Models, Biological | 1 | 2017 | 1636 | 0.180 |
Why?
| | Molecular Structure | 3 | 2012 | 438 | 0.180 |
Why?
| | Kinetics | 3 | 2014 | 1559 | 0.170 |
Why?
| | Biocatalysis | 2 | 2014 | 60 | 0.170 |
Why?
| | Leukopoiesis | 1 | 2019 | 10 | 0.160 |
Why?
| | Myeloid Progenitor Cells | 1 | 2019 | 15 | 0.160 |
Why?
| | NADPH Oxidase 2 | 1 | 2019 | 42 | 0.160 |
Why?
| | Cardio-Renal Syndrome | 1 | 2019 | 10 | 0.160 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.160 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 20 | 0.160 |
Why?
| | Cell Self Renewal | 1 | 2019 | 49 | 0.160 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 138 | 0.160 |
Why?
| | Asparagine | 1 | 2018 | 29 | 0.160 |
Why?
| | Xanthine | 1 | 2018 | 7 | 0.160 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 158 | 0.160 |
Why?
| | Blood Banks | 1 | 2018 | 40 | 0.160 |
Why?
| | Aspartic Acid | 1 | 2018 | 78 | 0.160 |
Why?
| | Arousal | 1 | 2019 | 151 | 0.150 |
Why?
| | Proteostasis | 1 | 2018 | 20 | 0.150 |
Why?
| | Aging | 2 | 2018 | 1624 | 0.150 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 14 | 0.150 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.150 |
Why?
| | Methods | 1 | 2017 | 59 | 0.150 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.150 |
Why?
| | Hypoxanthine | 1 | 2017 | 10 | 0.150 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.150 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 14 | 0.150 |
Why?
| | Glutaminase | 1 | 2017 | 10 | 0.150 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 19 | 0.150 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 20 | 0.150 |
Why?
| | Sphingosine | 1 | 2017 | 33 | 0.150 |
Why?
| | Benzothiazoles | 1 | 2017 | 33 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
| | Signal Transduction | 4 | 2018 | 4526 | 0.150 |
Why?
| | Sciuridae | 1 | 2019 | 142 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 413 | 0.140 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2017 | 43 | 0.140 |
Why?
| | Lysophospholipids | 1 | 2017 | 65 | 0.140 |
Why?
| | Rabbits | 2 | 2019 | 750 | 0.140 |
Why?
| | Solubility | 1 | 2017 | 224 | 0.140 |
Why?
| | Models, Molecular | 3 | 2018 | 1379 | 0.140 |
Why?
| | Phenylurea Compounds | 1 | 2017 | 82 | 0.140 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 81 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2018 | 474 | 0.140 |
Why?
| | Leukemia | 1 | 2019 | 209 | 0.140 |
Why?
| | Fibronectins | 2 | 2018 | 108 | 0.140 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1477 | 0.140 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 126 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.140 |
Why?
| | Adenosine Triphosphate | 2 | 2019 | 431 | 0.130 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 318 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2018 | 254 | 0.130 |
Why?
| | Lactic Acid | 1 | 2018 | 278 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 53 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.130 |
Why?
| | Esters | 2 | 2011 | 61 | 0.130 |
Why?
| | Apolipoproteins | 1 | 2015 | 36 | 0.130 |
Why?
| | Workflow | 1 | 2017 | 136 | 0.130 |
Why?
| | Ischemia | 1 | 2019 | 363 | 0.130 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 348 | 0.130 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 76 | 0.130 |
Why?
| | Inflammation Mediators | 2 | 2019 | 476 | 0.120 |
Why?
| | Cyclohexanones | 2 | 2016 | 8 | 0.120 |
Why?
| | Protein Stability | 2 | 2016 | 157 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 217 | 0.120 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2212 | 0.120 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2018 | 29 | 0.110 |
Why?
| | Time Factors | 4 | 2019 | 6143 | 0.110 |
Why?
| | Healthy Volunteers | 2 | 2019 | 197 | 0.110 |
Why?
| | Sulfonamides | 2 | 2018 | 446 | 0.110 |
Why?
| | Peroxiredoxin III | 1 | 2013 | 1 | 0.110 |
Why?
| | Amino Acid Sequence | 2 | 2018 | 1990 | 0.110 |
Why?
| | Sulfinic Acids | 1 | 2013 | 7 | 0.110 |
Why?
| | Nitrogen Isotopes | 2 | 2017 | 55 | 0.110 |
Why?
| | Disulfides | 1 | 2013 | 90 | 0.110 |
Why?
| | Carbon Isotopes | 2 | 2017 | 112 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 353 | 0.110 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 447 | 0.100 |
Why?
| | Half-Life | 1 | 2012 | 143 | 0.100 |
Why?
| | Critical Illness | 1 | 2017 | 645 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 638 | 0.100 |
Why?
| | Female | 11 | 2019 | 59621 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2017 | 482 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2013 | 791 | 0.100 |
Why?
| | Swine | 3 | 2018 | 704 | 0.100 |
Why?
| | Hypoxia | 1 | 2017 | 959 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 603 | 0.090 |
Why?
| | Carrageenan | 1 | 2011 | 6 | 0.090 |
Why?
| | Naproxen | 1 | 2011 | 11 | 0.090 |
Why?
| | Rats | 3 | 2018 | 4974 | 0.090 |
Why?
| | Gastric Mucosa | 1 | 2011 | 46 | 0.090 |
Why?
| | Stereoisomerism | 1 | 2011 | 91 | 0.090 |
Why?
| | Male | 11 | 2019 | 55739 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2011 | 72 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2016 | 956 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2019 | 3896 | 0.090 |
Why?
| | Ibuprofen | 1 | 2011 | 73 | 0.090 |
Why?
| | Edema | 1 | 2011 | 119 | 0.090 |
Why?
| | Cell Line | 2 | 2016 | 2645 | 0.080 |
Why?
| | Plasticizers | 1 | 2019 | 12 | 0.080 |
Why?
| | Succinate Dehydrogenase | 1 | 2019 | 42 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2796 | 0.080 |
Why?
| | Vasoconstrictor Agents | 1 | 2019 | 112 | 0.080 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 175 | 0.080 |
Why?
| | Caspases, Initiator | 1 | 2018 | 18 | 0.080 |
Why?
| | Liver X Receptors | 1 | 2018 | 30 | 0.080 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2018 | 35 | 0.080 |
Why?
| | Pulmonary Surfactants | 1 | 2019 | 101 | 0.080 |
Why?
| | Organ Size | 1 | 2019 | 444 | 0.080 |
Why?
| | Methionine | 1 | 2018 | 145 | 0.080 |
Why?
| | Mutation | 2 | 2013 | 3350 | 0.070 |
Why?
| | Glycogen Phosphorylase | 1 | 2017 | 4 | 0.070 |
Why?
| | Solutions | 1 | 2018 | 148 | 0.070 |
Why?
| | Glutathione | 1 | 2019 | 302 | 0.070 |
Why?
| | Biological Transport | 1 | 2018 | 372 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 213 | 0.070 |
Why?
| | Cell Respiration | 1 | 2017 | 74 | 0.070 |
Why?
| | Azacitidine | 1 | 2018 | 129 | 0.070 |
Why?
| | Caspase 1 | 1 | 2018 | 140 | 0.070 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 176 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2716 | 0.070 |
Why?
| | Hemoglobins | 2 | 2018 | 315 | 0.070 |
Why?
| | Immune System | 1 | 2018 | 172 | 0.070 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 172 | 0.070 |
Why?
| | Lipoproteins | 1 | 2018 | 160 | 0.070 |
Why?
| | Parenteral Nutrition | 1 | 2018 | 93 | 0.070 |
Why?
| | Trachea | 1 | 2019 | 234 | 0.070 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 227 | 0.070 |
Why?
| | Hepatocytes | 1 | 2018 | 196 | 0.070 |
Why?
| | Caspases | 1 | 2018 | 245 | 0.070 |
Why?
| | Immunologic Factors | 1 | 2019 | 221 | 0.070 |
Why?
| | Pregnancy | 2 | 2019 | 5521 | 0.070 |
Why?
| | Glutamine | 2 | 2017 | 91 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1037 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1736 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 193 | 0.070 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2016 | 13 | 0.070 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2016 | 15 | 0.070 |
Why?
| | Cell Proliferation | 2 | 2017 | 2191 | 0.070 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2016 | 23 | 0.070 |
Why?
| | Inflammation | 1 | 2016 | 2485 | 0.070 |
Why?
| | History, Ancient | 1 | 2016 | 48 | 0.070 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 74 | 0.060 |
Why?
| | Cell Lineage | 1 | 2017 | 310 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2018 | 1229 | 0.060 |
Why?
| | Vasodilation | 1 | 2018 | 417 | 0.060 |
Why?
| | Cytokines | 2 | 2017 | 1843 | 0.060 |
Why?
| | Immunoblotting | 1 | 2016 | 282 | 0.060 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 388 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2016 | 94 | 0.060 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 299 | 0.060 |
Why?
| | Homeostasis | 1 | 2018 | 578 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1435 | 0.060 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 305 | 0.060 |
Why?
| | Molecular Probes | 1 | 2014 | 30 | 0.060 |
Why?
| | Isometric Contraction | 1 | 2016 | 154 | 0.060 |
Why?
| | Peptide Mapping | 1 | 2014 | 60 | 0.060 |
Why?
| | Cell Survival | 1 | 2017 | 1022 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 817 | 0.060 |
Why?
| | Oxygen | 1 | 2018 | 854 | 0.060 |
Why?
| | Adult | 5 | 2019 | 30659 | 0.060 |
Why?
| | Iodoacetamide | 1 | 2013 | 5 | 0.060 |
Why?
| | Methyl Methanesulfonate | 1 | 2013 | 5 | 0.060 |
Why?
| | Ethylmaleimide | 1 | 2013 | 18 | 0.060 |
Why?
| | Radiation, Ionizing | 1 | 2014 | 72 | 0.060 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 675 | 0.050 |
Why?
| | HeLa Cells | 1 | 2014 | 562 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 556 | 0.050 |
Why?
| | Hypoglycemia | 1 | 2017 | 386 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2013 | 110 | 0.050 |
Why?
| | Myocardium | 2 | 2019 | 922 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2017 | 1955 | 0.050 |
Why?
| | Pneumonia | 1 | 2017 | 568 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1133 | 0.050 |
Why?
| | Microbiota | 1 | 2018 | 648 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1523 | 0.050 |
Why?
| | Protein Binding | 1 | 2016 | 1898 | 0.040 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1857 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2017 | 1700 | 0.040 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 25 | 0.040 |
Why?
| | Myoglobin | 1 | 2010 | 14 | 0.040 |
Why?
| | Guanylate Cyclase | 1 | 2010 | 32 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2799 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2010 | 53 | 0.040 |
Why?
| | Catalase | 1 | 2010 | 117 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1317 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 108 | 0.040 |
Why?
| | Aza Compounds | 1 | 2009 | 11 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 6 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2018 | 12 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 27 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2329 | 0.040 |
Why?
| | Sulfur | 1 | 2019 | 46 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2016 | 3015 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 84 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 192 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 182 | 0.040 |
Why?
| | Hibernation | 1 | 2019 | 72 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 171 | 0.040 |
Why?
| | Water | 1 | 2011 | 409 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 208 | 0.040 |
Why?
| | Tryptophan | 1 | 2019 | 135 | 0.040 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1879 | 0.040 |
Why?
| | Antagomirs | 1 | 2017 | 13 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 198 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2017 | 17 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2018 | 125 | 0.040 |
Why?
| | Crush Injuries | 1 | 2017 | 10 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 15 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2017 | 48 | 0.040 |
Why?
| | Freezing | 1 | 2017 | 85 | 0.040 |
Why?
| | Swine, Miniature | 1 | 2017 | 71 | 0.040 |
Why?
| | Lactates | 1 | 2017 | 84 | 0.040 |
Why?
| | Infant, Newborn | 1 | 2018 | 5040 | 0.040 |
Why?
| | Reference Standards | 1 | 2017 | 159 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2018 | 430 | 0.040 |
Why?
| | Mice, Nude | 1 | 2018 | 631 | 0.040 |
Why?
| | Primates | 1 | 2018 | 111 | 0.040 |
Why?
| | Femoral Fractures | 1 | 2017 | 67 | 0.040 |
Why?
| | Chemical Fractionation | 1 | 2016 | 28 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 405 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 590 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3118 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 168 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 146 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
| | Databases, Protein | 1 | 2016 | 59 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 91 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 239 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 339 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 557 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 143 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2017 | 188 | 0.030 |
Why?
| | Apolipoprotein L1 | 1 | 2015 | 12 | 0.030 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2017 | 198 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 211 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 559 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 437 | 0.030 |
Why?
| | Trauma Centers | 1 | 2017 | 325 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 697 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 924 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6357 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 322 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 344 | 0.030 |
Why?
| | Fibroblasts | 1 | 2017 | 839 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1812 | 0.030 |
Why?
| | Kidney | 1 | 2019 | 1186 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 350 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 26831 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 849 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 850 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2815 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 876 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3335 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4089 | 0.020 |
Why?
| | Aged | 1 | 2016 | 19122 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2108 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2380 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 1729 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 8642 | 0.010 |
Why?
|
|
Haines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|